FDA Follows EMA toward Follow-On Biologics

08.08.2011

EMA published guidelines for follow-on biologics in 2005, and FDA has been studying its peer’s approach. So far it appears that FDA will follow EMA's strategy of taking a product-specific approach to approving follow-on biologics.

Read more on PharmaTech.